| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C. |
|
Medicine details |
|
| Medicine name | dasabuvir (Exviera®) |
| Formulation | 250 mg film-coated tablet |
| Reference number | 2599 |
| Indication | In combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults |
| Company | AbbVie Ltd |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 07/01/2015 |
| NICE guidance | TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C |